Log In

    Tonix Pharmaceuticals Holding Corp. (TNXP)

    New Tianeptine Data In Memory and Cognition Announced

    ‌
    Robert LeBoyerMedia Inquiries
    Senior Life Sciences Analyst
    July 25, 2023
    Report ID: 25976
    Get Report
    Refer to the full report for the price target, fundamental analysis, and rating.
    Get Report

    Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

    Already Registered? Click the ‘Get Report’ button to login and view the research report.

    Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

    ‌
    Tonix Pharmaceuticals Holding Corp.
    Ticker
    TNXP
    Current Price
    $0.55 -5.09%
    Market Cap
    $1.6M
    Price Target
    Refer to Report
    Volume
    1.8M
    52wk Range
    $0.462 - $58.24
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Related Research Reports
    6/21/2024
    ‌
    Tonix Announces Positive Pre-NDA Meeting – NDA Submission On Schedule
    Tonix Announces Positive Pre-NDA Meeting – NDA Submission On Schedule (TNXP)
    0 min read
    5/31/2024
    ‌
    Tonmya Presentations From Previous and Upcoming Trials
    Tonmya Presentations From Previous and Upcoming Trials (TNXP)
    0 min read
    4/11/2024
    ‌
    Increasing The Focus on Fibromyalgia
    Increasing The Focus on Fibromyalgia (TNXP)
    6 min read
    12/21/2023
    ‌
    Fibromyalgia Trial Meets All Endpoints
    Fibromyalgia Trial Meets All Endpoints (TNXP)
    2 min read

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In